Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients

American Journal of Transplantation

Volumn 10, Issue 5, 2010, Pages 1268-1275

  Coffin, C S ^a,i   Stock, P G ^a   Dove, L M ^b   Berg, C L ^c   Nissen, N N ^d   Curry, M P ^e   Ragni, M ^f   Regenstein, F G ^g   Sherman, K E ^h   Roland, M E ^a   Terrault, N A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d Cedars Sinai ^*  (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CALGARY   (Canada)

Author keywords

Hepatitis B immunoglobulin; Hepatitis B virus (HBV); Immune deficiency; Polymerase chain reaction; Posttransplant; Posttransplant complications; Posttransplant mortality; Surface (S) gene

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; EMTRICITABINE; ENTECAVIR; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NUCLEOSIDE ANALOG; NUCLEOTIDE DERIVATIVE; OKT 3; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; TENOFOVIR; VIRUS DNA;

ACUTE GRAFT REJECTION; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTERSTITIAL NEPHRITIS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; MIXED INFECTION; MULTICENTER STUDY; NEPHROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; VIREMIA;

ADULT; AGED; ANTIVIRAL AGENTS; GRAFT SURVIVAL; HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HIV; HIV INFECTIONS; HUMANS; IMMUNOGLOBULINS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFECTION; LAMIVUDINE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME; VIRUS DISEASES; VIRUSES;

EID: 77951219796     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03070.x     Document Type: Article

References (37)

1. Samuel D, Weber R, Stock P, Duclos-Vallee JC, Terrault N. Are HIV-infected patients candidates for liver transplantation? J Hepatol 2008 48 : 697 707.
2. Soriano V, Barreiro P, Nunez M. Management of chronic hepatitis B and C in HIV-coinfected patients. J Antimicrob Chemother 2006 57 : 815 818.
3. Soriano V, Puoti M, Bonacini M et al. Care of patients with chronic hepatitis B and HIV co-infection: Recommendations from an HIV-HBV International Panel. AIDS 2005 19 : 221 240. (Pubitemid 40396554)
4. Roland ME, Stock PG. Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003 75 : 425 429.
5. Stock PG, Roland ME, Carlson L et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: A pilot safety and efficacy study. Transplantation 2003 76 : 370 375. (Pubitemid 36928001)
6. Castells L, Escartin A, Bilbao I et al. Liver transplantation in HIV-HCV coinfected patients: A case-control study. Transplantation 2007 83 : 354 358. (Pubitemid 46247870)
7. Norris S, Taylor C, Muiesan P et al. Outcomes of liver transplantation in HIV-infected individuals: The impact of HCV and HBV infection. Liver Transpl 2004 10 : 1271 1278. (Pubitemid 39406083)
8. Radecke K, Fruhauf NR, Miller M et al. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis. Liver Int 2005 25 : 101 108. (Pubitemid 40298252)
9. Schreibman I, Gaynor JJ, Jayaweera D et al. Outcomes after orthotopic liver transplantation in 15 HIV-infected patients. Transplantation 2007 84 : 697 705. (Pubitemid 47480654)
10. Vennarecci G, Ettorre GM, Antonini M et al. Liver transplantation in HIV-positive patients. Transplant Proc 2007 39 : 1936 1938. (Pubitemid 47198836)
11. Tateo M, Roque-Afonso AM, Antonini TM et al. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: Perfect control of hepatitis B virus replication and absence of mitochondrial toxicity. AIDS 2009 23 : 1069 1076.
12. Raimondo G, Allain JP, Brunetto MR et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008 49 : 652 657.
13. Mulrooney-Cousins PM, Michalak TI. Persistent occult hepatitis B virus infection: Experimental findings and clinical implications. World J Gastroenterol 2007 13 : 5682 5686.
14. Roche B, Feray C, Gigou M et al. HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis. Hepatology 2003 38 : 86 95. (Pubitemid 36775799)
15. Roland ME, Barin B, Carlson L et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 2008 8 : 355 365.
16. Terrault NA, Carter JT, Carlson L, Roland ME, Stock PG. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transpl 2006 12 : 801 807.
17. McMahon MA, Jilek BL, Brennan TP et al. The HBV drug entecavir - effects on HIV-1 replication and resistance. N Engl J Med 2007 356 : 2614 2621.
18. Liu Y, Hussain M, Wong S, Fung SK, Yim HJ, Lok AS. A genotype-independent real-time PCR assay for quantification of hepatitis B virus DNA. J Clin Microbiol 2007 45 : 553 558. (Pubitemid 46272077)
19. Angus P, Vaughan R, Xiong S et al. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology 2003 125 : 292 297. (Pubitemid 36929407)
20. Coffin CS, Mulrooney-Cousins PM, Lee SS, Michalak TI, Swain MG. Profound suppression of chronic hepatitis C following superinfection with hepatitis B virus. Liver Int 2007 27 : 722 726. (Pubitemid 47097325)
21. Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Investigation 1994 93 : 230 239. (Pubitemid 24030841)
22. Duclos-Vallee J, Feray C, Sebagh M et al. Liver transplantation of HIV-HCV and HIV-HBV coinfected patients: A large experience in a single-centre. J Hepatol 2006 44 (Suppl 2 S8.
23. Fung J, Eghtesad B, Patel-Tom K, DeVera M, Chapman H, Ragni M. Liver transplantation in patients with HIV infection. Liver Transpl 2004 10 (10 Suppl 2 S39 S53. (Pubitemid 39406100)
24. Vogel M, Voigt E, Schafer N et al. Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: Outcome of 7 patients from the Bonn cohort. Liver Transpl 2005 11 : 1515 1521. (Pubitemid 43072627)
25. Coffin CS, Terrault NA. Management of hepatitis B in liver transplant recipients. J Viral Hepat 2007 14 (Suppl 1 37 44. (Pubitemid 47624113)
26. Terrault N. Treatment of recurrent hepatitis B infection in liver transplant recipients. Liver Transpl 2002 8 (10 Suppl 1 S74 S81. (Pubitemid 35154047)
27. Ciesek S, Helfritz FA, Lehmann U et al. Persistence of occult hepatitis B after removal of the hepatitis B virus-infected liver. J Infect Dis 2008 197 : 355 360. (Pubitemid 351263416)
28. Petit MA, Buffello-Le Guillou D, Roche B et al. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen. J Med Virol 2001 65 : 493 504. (Pubitemid 32959075)
29. Araujo NM, Branco-Vieira M, Silva AC et al. Occult hepatitis B virus infection in HIV-infected patients: Evaluation of biochemical, virological and molecular parameters. Hepatol Res 2008 38 : 1194 1203.
30. Filippini P, Coppola N, Pisapia R et al. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. AIDS 2006 20 : 1253 1260. (Pubitemid 44030373)
31. Hofer M, Joller-Jemelka HI, Grob PJ, Luthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV cohort study. Eur J Clin Microbiol Infect Dis 1998 17 : 6 13. (Pubitemid 28072282)
32. Piroth L, Lafon ME, Binquet C et al. Occult hepatitis B in HIV-HCV coinfected patients. Scand J Infect Dis 2008 40 : 835 839.
33. Pogany K, Zaaijer HL, Prins JM, Wit FW, Lange JM, Beld MG. Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients. AIDS Res Hum Retrov 2005 21 : 922 926. (Pubitemid 41785777)
34. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Bréchot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely "occult"? Hepatology 2001 34 : 194 203. (Pubitemid 32591500)
35. Zerbini A, Pilli M, Boni C et al. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. Gastroenterology 2008 134 : 1470 1481. (Pubitemid 351615362)
36. Tur-Kaspa R, Burk RD, Shaul Y, Shafritz DA. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci U S A 1986 83 : 1627 1631. (Pubitemid 16018617)
37. Palacios Mata, Hidalgo Munoz, Viciana Del A et al. Very low prevalence and No clinical significance of occult hepatitis B in a cohort of HIV-infected patients with isolated anti-HBc seropositivity: The BHOI study. HIV Clin Trials 2008 9 : 337 340.